IL13 and Alzheimer disease: In AD mice models, the treatment with anti-miR-155-5p inhibitors clearly reduced the thinning of the epidermis and reduction of the inflammatory skin cell infiltrates accompanied by decreasing levels of Th2 cytokines (IL-4, IL-5, IL-9 and IL-13) [85].